Tg(tetO-APPSwInd)18Dbo
Transgene Detail

Summary

• Symbol: Tg(tetO-APPSwInd)18Dbo
• Name: transgene insertion 18, David R Borchelt
• MGI ID: MGI:3709065
• Synonyms: tet-APPswe/ind line 18, Tg(tetO-APP*Swe*Ind)18Dbo
• Transgene: Tg(tetO-APPSwInd)18Dbo Location: unknown
• Alliance: Tg(tetO-APPSwInd)18Dbo page

Transgene origin

• Strain of Origin: (C57BL/6J x C3H/HeJ)F1

Transgene description

• Transgene Type: Transgenic (Humanized sequence, Inducible, Inserted expressed sequence)
• Inducer: doxycycline/tetracycline
• Mutation: Insertion
• Tg(tetO-APPSwInd)18Dbo expresses 1 gene
  Transgene expresses:
  

  Organism	Expressed Gene	Note
  mouse	App (MGI:88059)	The gene encodes a humanized amyloid beta domain and incorporates the Swedish mutation.

• Tg(tetO-APPSwInd)18Dbo expression driven by 1 gene
  Transgene expression driven by:
  

  Organism	Driver Gene	Note
  Not Specified	tetO

• Mutation details: The mouse amyloid beta (A4) precursor protein (APP) sequence was modified to contain a humanized amyloid-beta (Abeta) domain. This mouse/human chimeric APP (mo/huAPP695 or APP695) was mutated to incorporate the Swedish (KM570/571NL) and Indiana (V617F) APP mutations associated with Alzheimer's disease. This APP695swe/ind sequence was placed downstream of the tetracycline-responsive (TRE or tetO) promoter and mouse prion protein exons 1-2. (J:109829)

Disease models

Find Mice (IMSR)

• Mouse strains and cell lines available from the International Mouse Strain Resource (IMSR)
• Carrying this Mutation: Mouse Strains: 0 strains available Cell Lines: 0 lines available

References

• Original: J:109829 Jankowsky JL, et al., Persistent amyloidosis following suppression of Abeta production in a transgenic model of Alzheimer disease. PLoS Med. 2005 Dec;2(12):e355
• All: 1 reference(s)